Literature DB >> 10051132

Effect of acute and long-term treatment with 17-beta-estradiol on the vasomotor responses in the rat aorta.

H L Andersen1, J U Weis, B Fjalland, N Korsgaard.   

Abstract

1. This study sought to evaluate whether the effects of acute and long-term treatment with 17-beta-estradiol on the vasomotor responses in rat aortic rings are mediated through the same mechanism. 2. Ovariectomized rats were treated daily with either 17-beta-estradiol-3-benzoate (100 microg kg(-1)) or vehicle for 1 week. 3. The effect of long-term 17-beta-estradiol treatment on the responses to cumulative doses of phenylephrine, 5-HT, calcium, potassium and 17-beta-estradiol was determined in aortic rings. In the same rings, the effect of acute exposure to 17-beta-estradiol (5 and 10 microM) on the dose response curves for phenylephrine, 5-HT, calcium, potassium and acetylcholine were estimated. The measurements were made in rings with and without intact endothelium. The tone-related basal release of nitric oxide (NO) was measured in rings with intact endothelium. 4. Long-term 17-beta-estradiol treatment reduced the maximum developed contraction to all contracting agents studied. This effect was abolished in endothelium denuded vessels. Acute 17-beta-estradiol treatment also reduced maximal contraction. This effect, however, was independent of the endothelium. 5. Long-term 17-beta-estradiol treatment significantly increased the ability of the rings to dilate in response to acetylcholine whereas acute exposure to 17-beta-estradiol had no effect. The tone-related release of NO was significantly increased after long-term exposure to 17-beta-estradiol. 6. In conclusion, this study indicate that the acute and long-term effects of 17-beta-estradiol in the rat aorta are mediated through different mechanisms. The long-term effect is mediated through the endothelium most likely by increasing NO release. In contrast, the acute effect of 17-beta-estradiol seems to be through an effect on the vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051132      PMCID: PMC1565793          DOI: 10.1038/sj.bjp.0702289

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  64 in total

1.  17 beta-Oestradiol inhibits stimulated endothelin release in human vascular endothelial cells.

Authors:  C S Wingrove; J C Stevenson
Journal:  Eur J Endocrinol       Date:  1997-08       Impact factor: 6.664

2.  Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca(2+)-dependent K+ channels.

Authors:  G C Wellman; A D Bonev; M T Nelson; J E Brayden
Journal:  Circ Res       Date:  1996-11       Impact factor: 17.367

3.  Non-genomic mechanism of 17 beta-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle.

Authors:  T Kitazawa; E Hamada; K Kitazawa; A K Gaznabi
Journal:  J Physiol       Date:  1997-03-01       Impact factor: 5.182

4.  In vivo effects of angiotensin II on vascular smooth muscle contraction and blood pressure are mediated through a protein tyrosine-kinase-dependent mechanism.

Authors:  M D Sauro; R Sudakow; S Burns
Journal:  J Pharmacol Exp Ther       Date:  1996-06       Impact factor: 4.030

5.  Human vascular smooth muscle cells contain functional estrogen receptor.

Authors:  R H Karas; B L Patterson; M E Mendelsohn
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

6.  Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells.

Authors:  K Hishikawa; T Nakaki; T Marumo; H Suzuki; R Kato; T Saruta
Journal:  FEBS Lett       Date:  1995-03-06       Impact factor: 4.124

7.  Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit.

Authors:  R S Kushwaha; W R Hazzard
Journal:  Metabolism       Date:  1981-04       Impact factor: 8.694

8.  Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit.

Authors:  V Gisclard; V M Miller; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1988-01       Impact factor: 4.030

9.  Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle.

Authors:  W Abebe; D K Agrawal
Journal:  J Cardiovasc Pharmacol       Date:  1995-07       Impact factor: 3.105

10.  Effects of tyrosine kinase inhibitors on the contractility of rat mesenteric resistance arteries.

Authors:  C Toma; P E Jensen; D Prieto; A Hughes; M J Mulvany; C Aalkjaer
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

View more
  15 in total

1.  Cutaneous postural vasoconstriction is modified by exogenous but not endogenous female hormones in young women.

Authors:  Gemma D Bishop; Margaret D Brown
Journal:  Clin Auton Res       Date:  2007-01-30       Impact factor: 4.435

2.  Na+ -K+ -2Cl- cotransporter is implicated in gender differences in the response of the rat aorta to phenylephrine.

Authors:  Javier Palacios; Francisco Espinoza; Carolina Munita; Fredi Cifuentes; Luis Michea
Journal:  Br J Pharmacol       Date:  2006-06-26       Impact factor: 8.739

3.  Vasorelaxant effect of 17α-ethynylestradiol on human saphenous vein.

Authors:  Ahmad Reza Jodati; Hossein Babaei; Yadollah Azarmi; Sahar Fallah; Afsaneh Gharebageri; Danial Fadaei Fouladi; Naser Safaei
Journal:  Adv Pharm Bull       Date:  2015-03-05

Review 4.  Vascular effects of ovariectomy and chronic oestrogen treatment in rats: controversy or experimental protocol diversity?

Authors:  Thierry Chataigneau; Valérie B Schini-Kerth
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

5.  Reciprocal changes in endothelium-derived hyperpolarizing factor- and nitric oxide-system in the mesenteric artery of adult female rats following ovariectomy.

Authors:  Satoshi Nawate; Mitsuhiro Fukao; Ichiro Sakuma; Takamitsu Soma; Kazuhiko Nagai; Osamu Takikawa; Soichi Miwa; Akira Kitabatake
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

6.  Mechanisms of 17 beta-oestradiol induced vasodilatation in isolated pressurized rat small arteries.

Authors:  L Shaw; M J Taggart; C Austin
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

7.  17beta-estradiol attenuates vascular contraction through inhibition of RhoA/Rho kinase pathway.

Authors:  Enyue Yang; Su Bun Jeon; Inji Baek; Zheng-Ai Chen; Zheng Jin; In Kyeom Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-03-19       Impact factor: 3.000

8.  Pharmacological evidence for a key role of voltage-gated K+ channels in the function of rat aortic smooth muscle cells.

Authors:  Paolo Tammaro; Amy L Smith; Simon R Hutchings; Sergey V Smirnov
Journal:  Br J Pharmacol       Date:  2004-08-23       Impact factor: 8.739

9.  Chronic treatment of male rats with daidzein and 17 beta-oestradiol induces the contribution of EDHF to endothelium-dependent relaxation.

Authors:  Owen L Woodman; Mirna Boujaoude
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739

10.  Effect of phenylephrine and endothelium on vasomotion in rat aorta involves potassium uptake.

Authors:  Javier Palacios; José Luis Vega; Adrián Paredes; Fredi Cifuentes
Journal:  J Physiol Sci       Date:  2012-11-20       Impact factor: 2.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.